(Q42480021)

English

Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic Adipocytes

scientific article published on November 17, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic Adipocytes (English)

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sabrina Bauer

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Josef Wanninger

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sandra Schmidhofer

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Johanna Weigert

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Markus Neumeier

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Christoph Dorn

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Claus Hellerbrand

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Nicole Zimara

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Andreas Schäffler

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Charalampos Aslanidis

10

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Christa Buechler

11

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

17 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

full work available at URL

https://academic.oup.com/endo/article-pdf/152/1/26/9008388/endo0026.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21084441

28 August 2024

http://intl-endo.endojournals.org/cgi/content/abstract/152/1/26

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21084441

28 August 2024

http://academic.oup.com/endo/article-pdf/152/1/26/9008388/endo0026.pdf

Portable Document Format

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

152

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

26-35

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes

1

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences

2

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

3

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases

4

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

5

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Cholesterol imbalance in adipocytes: a possible mechanism of adipocytes dysfunction in obesity

6

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors

7

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes

8

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Adipocyte cholesterol balance in obesity

9

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Adipokines and insulin resistance

10

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

11

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

12

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study

13

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.

14

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells.

15

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

TNF-alpha and adipocyte biology

16

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro

17

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}.

18

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

19

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin--a new adipokine that modulates adipogenesis via its own receptor.

20

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes.

21

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Insulin and metformin regulate circulating and adipose tissue chemerin

22

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands

23

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes

24

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans

25

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes

26

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro.

27

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Variation in susceptibility to atherosclerosis among inbred strains of mice

28

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Preadipocyte response and impairment of differentiation in an inflammatory environment

30

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release

31

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone

32

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Induction of aP2 gene expression by nonmetabolized long-chain fatty acids

33

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes

34

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

SREBPs: protein interaction and SREBPs

35

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

36

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Inflammation and impaired adipogenesis in hypertrophic obesity in man.

37

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Toll-like receptor ligands cause proinflammatory and prodiabetic activation of adipocytes via phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase but not interferon regulatory factor-3.

38

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes

39

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity

40

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Diet dependence of diabetes in the New Zealand Obese (NZO) mouse: total fat, but not fat quality or sucrose accelerates and aggravates diabetes

41

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression.

42

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

43

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin reveals its chimeric nature

44

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes

45

1 reference

10.1210/EN.2010-1157

https://api.crossref.org/works/10.1210/EN.2010-1157

28 August 2024

Identifiers

10.1210/EN.2010-1157

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42480021&oldid=2238779241"